tiprankstipranks
Revolution Medicines (RVMD)
NASDAQ:RVMD

Revolution Medicines (RVMD) Financial Statements

218 Followers

Revolution Medicines Financial Overview

Revolution Medicines's market cap is currently ―. The company's EPS TTM is $-3.76; its P/E ratio is -9.82; Revolution Medicines is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 742.00K-$ 3.82M$ 7.01M
Gross Profit-$ 742.00K-$ 3.82M$ 7.01M
EBIT$ -140.86M$ -132.39M$ -112.30M$ -98.30M$ -75.16M
EBITDA$ -138.10M$ -129.53M$ -115.26M$ -98.00M$ -76.17M
Net Income Common Stockholders$ -116.00M$ -161.54M$ -108.43M$ -98.30M$ -68.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.70B$ 1.85B$ 813.20M$ 909.49M$ 909.80M
Total Assets$ 1.91B$ 2.06B$ 984.23M$ 1.07B$ 1.07B
Total Debt$ 88.03M$ 87.94M$ 62.85M$ 63.26M$ 63.60M
Net Debt$ -1.62B$ -1.77B$ -750.35M$ -846.23M$ -846.20M
Total Liabilities$ 182.90M$ 235.51M$ 146.77M$ 142.87M$ 121.03M
Stockholders Equity$ 1.68B$ 1.83B$ 837.46M$ 930.87M$ 952.22M
Cash Flow-
Free Cash Flow$ -163.73M$ -122.88M$ -103.03M$ 300.00K$ -64.12M
Operating Cash Flow$ -160.56M$ -120.56M$ -100.50M$ 300.00K$ -62.36M
Investing Cash Flow$ -247.97M$ -380.40M$ 77.35M-$ 4.00M
Financing Cash Flow$ 810.00K$ 839.35M$ 1.01M-$ 324.20M
Currency in USD

Revolution Medicines Earnings and Revenue History

Revolution Medicines Debt to Assets

Revolution Medicines Cash Flow

Revolution Medicines Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis